COVID-19 vaccination in Norway

This article needs to be updated. Please help update this article to reflect recent events or newly available information. (October 2021)

COVID-19 vaccination in Norway

COVID-19 vaccination site in Hamar
Date	27 December 2020 (2020-12-27) – present
Location	Norway
Cause	COVID-19 pandemic in Norway

Part of a series on the
COVID-19 pandemic
COVID-19 (disease) SARS-CoV-2 (virus) Cases Deaths
Timeline 2019 2020 January responses February responses March responses April responses May responses June responses July responses August responses September responses October responses November responses December responses 2021 January responses February responses March responses April responses May responses June responses July responses August responses September responses October responses November responses December responses 2022 January responses February responses March responses April responses May responses June responses July responses August responses September responses October responses November December 2023
Locations By country and territory Africa Antarctica Asia Europe North America Oceania South America By conveyance Cruise ships Naval ships
International response Endemic phase Evacuations Face masks International aid Origin Lockdowns by country Misinformation by governments Fake treatments Social distancing Software Travel United Nations World Health Organization WTO IP waiver Undercounting of deaths COVID-19 apps Zero-COVID National responses Africa China European Union Germany Ghana India Ireland Netherlands New Zealand Nigeria Philippines Russia Sweden UK government US federal government Vietnam
Medical response Disease testing Breathalyzer Development Drug development Drug repurposing Public health mitigation Vaccines History Research VITT Deployment Authorizations Operation Warp Speed Misinformation and hesitancy US Vaccine card Vaccine passports Current vaccines CoronaVac Covaxin Convidecia Janssen Medigen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sinopharm BIBP Sputnik V
Variants Variants of concern Alpha Beta Gamma Delta Omicron Other variants Epsilon Zeta Eta Theta Iota Kappa Lambda Mu Cluster 5 Lineage B.1.617
Economic impact and recession Arts and culture Aviation Cannabis Cinema films Disney Fashion Financial markets Food industry Food security Journalism Music Performing arts Retail Shipping Television US sportscasting programs Tourism Video games By country Canada India Ireland Malaysia New Zealand Russia UK US By sport Association football Baseball Basketball Combat sports Cricket Disc golf Gaelic games Gridiron football Ice hockey Motorsport Rugby league
Impacts Long COVID Neurological and psychological symptoms Post-exertional malaise Society Animals Alzheimer's disease patients Black people Crime Death rates by country Disability Domestic violence Emergency evacuations Education Female Environment Hospitals Language LGBT community Long-term care Media coverage Mental health Migration Military Notable deaths Other health issues Popular culture Protests Pregnancy Prisons Religion Catholic Church Hajj Science and technology Social media Strikes Suicides Telehealth Xenophobia and racism Politics Diplomacy Ireland Malaysia New Zealand Russia UK US
COVID-19 portal
v t e

COVID-19 vaccination in Norway is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. As of 21 June 2022 80.5% of the population have been vaccinated with the first dose, 75.1% with the second dose and 55.9% with at least one additional dose (also known as booster doses).^[1] As of 09 March 2023, a total of 14,443,131 vaccine doses has been distributed in Norway.^[2]

As of January 2022 the country offers both the Pfizer-BioNTech and Moderna vaccine for the population over 18 years old. It is possible for the population to choose the vaccine they want, and it is also possible to take different vaccines for the different doses. However, children under 18 years old are only given the Pfizer-BioNTech vaccine. The children under 15 years old need parental approval to be vaccinated, and they only get 1 dose of the Pfizer-BioTech vaccine. If they have some serious sickness, they may also get 2 doses. Only the children between 5 and 11 years old that have some serious sickness, will be offered the vaccine.^[3] Men between 18 and 30 years old are also recommended to choose to take the Pfizer-BioNTech due to the higher risk of getting myocarditis and pericarditis with the Moderna vaccine.^[4]

Norway is also closely monitoring side effects, with both reports from healthcare professionals and the public being registered in a common database. This should allow for a good overview of the situation once the vaccine is distributed in the general population, as well as an efficient collaboration with other countries. ^[5][6]

In May 2021, an expert review commissioned by the Norwegian Medicines Agency to investigate "the cause of the first 100 reported deaths of nursing home residents who had received the Pfizer-BioNTech vaccine" concluded that "a causal link between the Pfizer-BioNTech vaccine and death was considered "likely" in 10 of the 100 cases, "possible" in 26 cases, and "unlikely" in 59 cases. The remaining five were deemed "unclassifiable.""^[7]